Treatment Options for Protease Inhibitor-exposed Children

NCT01146873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS
HIV Infections

Interventions

DRUG: Efavirenz (EFV)
DRUG: Lopinavir/ritonavir (LPV/r)
DRUG: Stavudine (D4T)
DRUG: Abacavir (ABC)

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]